10x Genomics (TXG) Gross Margin (2018 - 2026)

10x Genomics (TXG) posted Gross Margin of 70.39% for Q1 2026, up 3.38% sequentially from 68.09% in Q4 2025, and up 231.0% YoY from 21.27% in Q1 2025.

10x Genomics (TXG) Gross Margin (2018 - 2026) Analysis & Trends

10x Genomics has reported Gross Margin for 9 years, with the latest figure at 70.39% in Q1 2026.

Quarterly Gross Margin rose 231.0% year-over-year to 70.39% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 69.6% (up 124.0% YoY) and the FY2025 annual result came in at 69.05%, up 119.0% from the prior year.
Gross Margin climbed to 70.39% in Q1 2026 per TXG's latest filing, from 68.09% in the prior quarter.
Over five years, Gross Margin peaked at 77.75% in Q1 2022 and troughed at 62.18% in Q3 2023.
A 5-year average of 70.04% and a median of 68.09% in 2025 frame the typical range for Gross Margin.
The sharpest annual moves came in 2022 and 2024: Gross Margin tumbled 1993 bps in 2022, then soared 798 bps in 2024.
Over 5 years, Gross Margin stood at 76.43% in 2022, then dropped by 18 bps to 62.93% in 2023, then rose by 7 bps to 67.24% in 2024, then gained by 1 bps to 68.09% in 2025, then gained by 3 bps to 70.39% in 2026.
According to Business Quant data, Gross Margin over the past three periods registered 70.39%, 68.09%, and 67.32% for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Gross Margin (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	74.98%
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	12.72%
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	72.27%
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	74.48%
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	86.44%
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	57.35%
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	69.44%
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	84.87%
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	83.00%
10	Privia Health	2.78 Bn	2.42 Bn	-	-

Download Data